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Abstract 
Although peanut allergy in children has gained increasing amounts of media attention 
over recent years, very little scientific study has been done regarding the 
emotional/behavioral impact that peanut allergy may have on children. The potential 
psychological effects have been mentioned by many medical researchers, but few studies 
have systematically investigated the link between peanut allergy and non-medical 
consequences. This study examined relationships between Health Related Quality of Life 
(HRQOL), child anxiety, and parental stress in a sample of children with peanut allergy. 
Families were recruited to complete a series of measures wherein 51 parents completed a 
demographic questionnaire, the Parenting Stress Index, a Pediatric Quality of Life 
Inventory (PedsQL 4.0), and a series of questions regarding their child’s peanut allergy. 
The 48 participants, ages 6 to 12 years, completed a Revised-Children’s Manifest 
Anxiety Scale, a PedsQL 4.0, and some specific questions regarding their peanut allergy. 
Regression analysis showed that child anxiety and parenting stress were found to 
significantly predict parent proxy-report of their child’s health related quality of life. 
Regression analysis also found that child anxiety, parenting stress, length of diagnosis, 
and not requiring an epinephrine shot for treatment predicted self-report of health-related 
quality of life in children with peanut allergy. Health-related quality of life in children 
with peanut allergy was affected not only by the severity of the allergy, but family 
reactions to the allergy. High levels of parenting stress and high levels of child anxiety 
seem to contribute to the experience of the allergy and should be considered when 
treating these families. Both medical personnel and mental health practitioners will need 
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to be aware of the potential impact of non-medical variables in order to assist families in 
dealing with this life-threatening and life-changing allergy. 
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 1 
Peanut Allergy in Children: Relationships to Health-Related Quality of Life, Anxiety, 
and Parental Stress 
Food allergy, the negative physiological reaction to proteins in food, is estimated 
to affect 20 percent of the world’s population (Anderson, 1997). In the United States, the 
three most common foods that cause allergic reactions in children are milk, eggs, and 
peanuts. Double-blind placebo-controlled food challenges, often considered the “gold 
standard” in food allergy testing, have been used to ascertain the current prevalence of 
food allergy in children. These studies indicate that the prevalence of true food allergy 
during the first three years of life is approximately 8% (Smith & McGhan, 2002). In older 
children and adults the rate is estimated to be 1 to 2 percent of the population (Anderson, 
1997). Seventy percent of people with food allergies are under the age of thirty and most 
of those people are under the age of six (Smith & McGhan, 2002).  
 The majority of food allergies and intolerances in children appear to be 
“outgrown.” Foods which are not tolerated early in life can sometimes be ingested with 
no difficulties at an older age; examples of this include dairy products and eggs. How 
quickly this developmental shift happens is often dependent on the severity of the initial 
allergic reaction. Less severe reactions such as hives usually mean that the allergy 
subsides sooner than if a more systemic reaction to the food occurred initially (Anderson, 
1997). Unfortunately, this tendency for symptoms to subside naturally is not true for all 
food allergies. Some surveys have found that individuals who have exhibited an allergy 
to peanuts have been found to still be allergic 14 years later, much is the same for 
allergies to tree nuts, fish, shellfish and some seeds, which also seem to be lifetime 
allergies (Anderson, 1997). Other researchers have found that peanut allergy does resolve 
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in approximately 20% of patients (Fleischer, Conover-Walker, Christie, Burks, & Wood, 
2003). That is, some children who were at one time found to be allergic to peanuts were 
able to tolerate peanuts and peanut substances in allergy tests several years later. 
Peanut Allergy  
The prevalence of peanut allergy is thought to be increasing. A survey in 1989 
estimated the prevalence at 0.6% in the United States (Sampson & Burke, 2000), while 
more recent surveys place the U.S. rate for adult allergy to peanuts and other nuts 
between 1.1 and 1.3% (National Institute of Environmental Health Sciences, 2002; 
Sampson, 2001).  
Emmett, Angus, Fry, and Lee (1999) studied both a cohort of children with peanut 
allergy and an adult group. They found that not only was the child cohort more sensitive, 
but they had had their first allergic reactions at a younger age. Fifty-six percent of the 
children had had their first allergic reaction to peanuts in the first two years of life, while 
75% of the adult sample did not have a reaction until after the age of 10 (Emmett et al., 
1999). It is not known if the difference in the average ages of onset between the two age 
groups is due to earlier exposure to peanut products in the younger age cohort. A group 
of French researchers (Moneret-Vautrin et al., 1998) found that, in their sample, 46% of 
those allergic to peanuts had their first symptoms before the age of 1 year (for 11 babies 
before the age of six months), and 34% between the ages of 1 and 3 years of age.  
A more recent study (Green et al., 2007) found that the mean age of first exposure 
to peanut proteins and the mean age of first reactions to peanuts have decreased over the 
last decade from means of 22 months at first exposure and 24 months at first reactions to 
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14 months at first exposure and 18 months at first reaction. Eighty three percent of the 
sample had an allergic reaction the first time they ingested peanuts.   
Peanuts are a difficult food to avoid because they are commonly added to many 
pre-packaged food items or processed in the same manufacturing plants as other foods. 
Yu et al. (2006) found an accidental annual ingestion rate for children with previously 
diagnosed peanut allergy to be 14.3%. Despite the vigilance of their parents, 29 children 
(of the 252 children followed) had 35 accidental exposures to peanuts over a period of 
244 patient years (most of the children had been followed for at least one year). Given the 
physiological impact, increasing numbers of medical researchers are investigating peanut 
allergies (Sampson, 2002). However, despite this enhanced research on the physiological 
and epidemiological characteristics of peanut allergy, less research has been done on the 
possible effects of having a peanut allergy in terms of these children’s quality of life and 
psychosocial functioning. In some cases, due to lack of research and information, 
researchers have simply proceeded with the belief that peanut allergy is probably very 
similar in its effects to other chronic illnesses like asthma, while acknowledging that 
peanut allergy may have different effects (Masia, Mullen, & Scotti, 1998). 
Symptoms and Types of Reactions 
Symptoms of peanut allergy can range from gastrointestinal distress to hives and 
rashes to respiratory problems (Smith & McGhan, 2002). Green et al. (2007) found that 
92% of a sample of 140 children had some type of skin change during their first allergic 
reaction to peanuts, 27% had gastrointestinal reactions (vomiting or diarrhea) and 17% 
reported respiratory symptoms. Sampson (2002) pointed out that severe allergic reactions 
to peanuts, including anaphylaxis, are often mistaken for a severe asthmatic reaction or 
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an acute cardiovascular event. This misdiagnosis can be complicated by the fact that 
people who have life-threatening reactions often also have a history of asthma. The rate 
of co-morbid asthma in people with peanut allergy has not been systematically measured, 
but has been found to affect anywhere between 41 to 68% of children with peanut allergy 
participating in research studies (Fleischer et al., 2003; Primeau et al., 2000; Simonte, 
Ma, Mofidi, & Sicherer, 2003) . 
The most frightening and serious consequence of exposure to an allergen such as 
peanuts is anaphylaxis. The course of an anaphylactic reaction in the case of food allergy 
can develop within minutes or up to a few hours after ingestion. Early anaphylactic 
symptoms may include oral tingling, a sensation of tightening airways, abdominal pain, 
nausea, vomiting, and skin flushing. These symptoms can progress into greater 
respiratory difficulty, hypotension, and dysrhythmias if left untreated, as typically 
develop in fatal and near-fatal cases. To qualify as a true anaphylactic reaction, the 
reaction is multi-systemic (involving more than one organ system) (Foucard & 
Malmheden-Yman, 2001). One study conducted in England found that almost four out of 
five patients suffering from anaphylaxis were under the age of 18 years old. In this under 
eighteen age group, three out of four anaphylactic reactions were caused by peanuts or 
tree nuts, compared with one out of four reactions in those over eighteen (Foucard & 
Malmheden-Yman, 2001).  Anaphylactic reactions should always be taken seriously and 
even if symptoms appear to dissipate after use of an epinephrine shot and a dose of 
diphenhydramine (Benadryl®), the person should be taken directly to the emergency 
room and be treated aggressively with intramuscular epinephrine, histamine H1 and H2 
receptor agonists, oxygen, inhaled albuterol, and systemic corticosteroids. It is also 
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suggested that, after an observation period of at least four hours, the person be put on a 
three-day course of oral prednisone and an antihistamine (Sampson, 2002). In a study by 
Sampson, Mendelson, and Rosen (1992), in 13 cases of fatal or near fatal anaphylactic 
shock, the difference between survival and death appeared directly related to the timing 
of the epinephrine shot. All deaths occurred in children or adolescents who did not 
receive an epinephrine shot within an hour of the accidental ingestion. 
In an estimated one third of allergic reactions to peanuts (Sampson, 2002), a 
“biphasic” reaction occurs, where symptoms that have seemed to dissipate come back in 
full force sometimes hours later and are more severe than the initial presentation. This 
second severe reaction often requires intubation and mechanical ventilation. For this 
reason someone who has had a reaction should go to a hospital even if the standard 
epinephrine shot appears to eliminate the reaction. As noted, someone who has had an 
allergic reaction to peanuts or other foods should be observed by qualified medical 
personnel for at least four hours after the initial reaction. 
The amount of exposure necessary to create an allergic reaction varies between 
individuals. A food allergy is said to be “severe” if the reactive exposure dose is less than 
100mg, and it is said to be “important” if the reactive dose is between 100mg and 1g, and 
“moderate” if the person can tolerate 10g or more (Moneret-Vautrin et al., 1998). 
According to a French study of 142 people who were allergic to peanuts, 87.5% of these 
people were in the important or severe range, and no people with peanut allergy could 
tolerate 10 grams or more (Moneret-Vautrin et al., 1998). While some people who are 
allergic to peanuts only have a reaction after eating them directly, some extremely 
sensitized individuals have reported reactions after contact with someone else who has 
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ingested or handled peanut products, and there have even been some reports of allergic 
reactions to peanuts when peanuts were merely in the room with the allergic individual 
(such as peanut dust in the ventilation system of an airplane) (Sampson, 2002). This 
potential for incidental exposure is especially of concern for children who often spend 
large amounts of time with other children and may not be able to control their 
environments, such as in school, daycare, or extracurricular activities. In fact, children 
who have a peanut allergy tend to be more sensitive than adults, exacerbating the 
difficulties in management. Emmett et al. (1999) reported that in a British sample of 
peanut allergic adults and children, 43% of the children reacted to smell, touch or taste of 
a peanut, while only 9% of the adults were this sensitive. In contrast, Simonte et al. 
(2003) found that in a sample of 30 children who had previously been categorized as 
strongly allergic to peanuts, none of the children experienced an allergic reaction after 
smelling peanut butter and only a handful of children experienced allergic symptoms (3 
with redness/swelling, 5 with itchiness) with direct skin contact with peanut butter. The 
authors concluded that peanut butter may be too oily to cause such indirect reactions, 
unlike peanuts that are roasted.   
Most children spend much of their time during the week in school, therefore 
recognition of allergic reactions and treatment is often in the hands of teachers and school 
nurses. Recently the magazine Newsweek (Kalb, 2007) reported that 18% of schools in 
the United States now ban peanuts entirely, but many schools try to manage each child’s 
allergy individually instead of instituting school-wide bans.  For the years 2001-2003, the 
state of Massachusetts collected data on the administration of epinephrine in schools 
(McIntyre, Sheetz, Carroll, & Young, 2005). They found that 48 school districts reported 
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a total of 115 administrations of epinephrine in which 31% of the shots were 
administered to children with known multiple allergies and 25% to children with an 
allergy to peanuts or tree nuts only. In 24% of cases, the individual was not known to 
have any life threatening allergies. And in cases of food allergy, the food substance 
causing the reaction was only identified in 43% of cases.  
Weiss, Munoz-Furlong, Furlong, and Arbit (2004) found that of 400 school nurses 
that they surveyed, 94% of the nurses reported having at least one student in their school 
with a severe food allergy; 32% reported having up to 4 students; 25% reported having 
up to 9 students; 37% reported having ten or more students to care for with severe food 
allergies. Ninety percent of the nurses reported that epinephrine was kept primarily in 
their offices, with only 19% reporting that students with food allergy were allowed to 
carry their own epinephrine. Nurses also reported epinephrine kept in a variety of other 
locations in their schools including: administrative offices (12%), allergic child’s 
classroom (5%), cafeteria (4%), every classroom (4%), and passed along from adult to 
adult as the child changed classrooms (10%). This lack of consistency among school 
nursing practices may reflect the lack of consistent emergency planning for children with 
life-threatening food allergies, that can vary across states, districts, and even school to 
school. 
There is some evidence that for the youngest sufferers, peanut allergy may not be 
a life-long problem. Although infants who have peanut allergy do tend to have more 
severe reactions as they get older, some studies have indicated that 20% of infants who 
have allergic reactions to peanuts may outgrow their allergy, especially if they have low 
levels of IgE antibodies in infancy (less than 5 kU per liter) (Sampson, 2002). In people 
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who are allergic to peanuts, one of the allergic mechanisms appears to be driven by anti-
bodies in the body that are built up against IgE proteins, which are found in peanuts. 
Because of these low levels of antibodies in the bloodstream, Sampson (2002) 
recommended that infants with low IgE levels should be tested periodically to ascertain 
their allergy status. Fleischer et al. (2003) recommended that not only infants, but older 
children be periodically re-tested for allergic reactions to peanuts, because an estimated 
20% of children will outgrow the allergy. 
In 1998, Great Britain advised pregnant and nursing women with a history of 
atopy (asthma, hives, hay fever, and eczema) to avoid peanut products (Dean et al., 
2007). Women were recruited and their children were followed for two years in order to 
ascertain whether precautions were taken and whether or not this precautionary 
avoidance was helpful in reducing the number of children with peanut allergy. At two 
year follow-up of the 545 families still in the study, 65% of the mothers had followed the 
advice, but personal or family history of atopic conditions was not related to avoidance. 
At two year follow-up, the rate of allergy to peanuts in the children was not reduced by 
avoidance of peanuts during pregnancy and lactation, holding steady at 2%. 
Diagnosis  
Zepf (2002) reported guidelines and recommendations on peanut allergy in 
children and acknowledged that the diagnosis of a food allergy is not always 
straightforward. Diagnosis may include a careful taking of the patient’s history as well as 
a skin-prick test for peanuts or radioallergosorbent testing (RAST), which looks for the 
blood concentration of IgE. IgE is one of five classes of antibodies found in the human 
body. As it circulates through the blood and lymph tissue, it binds to receptors on the 
 9 
surface of mast cells (a type of white blood cell). Once it binds, IgE it acts as an antenna, 
picking up signals of nearby allergens. When an allergen is present, in this case a peanut 
protein, IgE tells the mast cell to release histamine, which causes an inflammatory 
response in the nearby tissues. Mast cells are most concentrated in the skin and in the 
nasal and lung linings which are exposed to outside allergens. Inflammation of these 
tissues can cause rashes, runny noses, watery eyes, and respiratory distress (National 
Institute of Environmental Health Sciences, 2002). Patients who have an IgE level of at 
least 15 IU (International Units) per mL have a 95% or greater incidence of peanut 
allergy, which makes a potentially dangerous oral food challenge unnecessary as a 
diagnostic assessment.  For people with an IgE level of below 15 IU per mL and no clear 
history of peanut induced symptoms, a physician supervised food challenge is necessary 
to make a definitive diagnosis. Because such challenges can lead to severe anaphylactic 
symptoms, they should only be conducted in a hospital setting by an experienced 
specialist (Sampson, 2002). This risk may lead parents to choose to follow a peanut free 
diet for their child without an actual confirmation of diagnosis. 
Medical Treatment 
Management of peanut allergy consists of avoidance of all peanut products, 
including label reading of every ingested product and hyper vigilance regarding peanut 
products in one’s environment, training in recognition of early allergy symptoms, and 
training in the use of epinephrine shots (such as EpiPen® or Epi-EZ-Pen®) (Anderson, 
1997; Sampson, 2001; Zeph, 2002). According to the current standards of care and 
allergy management for people allergic to peanuts, medical practitioners recommend that 
every person who is allergic to peanuts have a written emergency plan and kit with 
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appropriate doses of diphenhydramine (Benedryl®) and epinephrine on hand at all times 
in case of accidental ingestion or exposure (Sampson, 2002). Also recommended is 
education for parents of children allergic to peanuts on possible methods of exposure, 
early signs of reactions and use of epinephrine shots (Jackson, 2002). These 
recommendations and daily vigilance over foods ingested and possible environmental 
contamination not only take time out of the day, but may affect quality of life.  
Health-Related Quality of Life 
 While the broad definition of quality of life encompasses a wide variety of areas 
including; home, work, school, and environmental factors; health related quality of life 
(HRQOL) refers to domains of a person’s health that are potentially within in the scope 
of the healthcare system (Seid, Varni, & Jacobs, 2000). Researchers and clinicians have 
begun to use quality of life measures to investigate total impact of illness on an individual 
as well as how the individual feels about their illness (Starfield & Riley, 1998). 
According to Levi and Drotar (1998), HRQOL assessment has several uses: (a) providing 
useful descriptive information regarding the health status of children with chronic 
conditions, (b) facilitating the identification of children with different levels of morbidity, 
and (c) increasing the understanding of children’s and adolescents’ perspectives on 
consequences and experiences of chronic illness.    
 While self reports of HRQOL have been deemed important by researchers, some 
researchers (Seid et al., 2000) emphasize that proxy report by caregivers is also important 
for two reasons; because (a) children rarely refer themselves for treatment, the parent’s 
perceptions are often the impetus to seek treatment and (b) very young and very ill 
children may not be able to fill out measures of HRQOL. There is also the question of 
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whether to use disease specific versus general measures of HRQOL. General measures of 
HRQOL are useful if one is assessing the differences between two illness groups. More 
illness-specific measures of HRQOL may be more useful clinically in comparing children 
with the same disease.  Levi and Drotar (1998) suggested a comprehensive approach that 
includes assessment of both general illness and level of functioning as well as more 
illness-specific information to evaluate smaller changes associated with specific diseases. 
While there are several general HRQOL scales that could be used with children with 
peanut allergy and their parents, currently there are no illness-specific measures of 
HRQOL for children with peanut allergy.  
Non-medical Impact 
While recent research has focused on the medical aspects of the effects of peanut 
allergy on children, there have been relatively few investigations into possible non-
medical effects specifically related to peanut allergy. In one such article (Masia et al., 
1998) a case study of a seven year old boy was described, who was referred due to 
symptoms of Obsessive-Compulsive Disorder secondary to a peanut allergy. In fact, all 
of the boy’s reported symptoms of OCD were centered around managing his allergy and 
the extreme lengths to which he was going in order to feel safe including; reported 
frequent thoughts of contamination, hand-washing, repeatedly asking his mother if items 
were safe to consume, refusing to eat food that had been in the vicinity of closed 
containers of peanut products, refusing to eat lunch at school, and avoiding all people 
(including school personnel) who might be contaminated. The child also reported waking 
up early in the morning, experiencing anaphylactic shock-like symptoms at the very sight 
of peanuts, and his pediatrician reported “a disturbing number of emergency situations” 
 12 
that had required epinephrine shots (Masia et al., 1998, p. 516). The authors 
acknowledged that this case seemed particularly extreme, but also emphasized that 
experiencing severe allergic reactions can be quite traumatic. In this case the authors 
noted that the child’s mother was possibly not taking her son’s allergy seriously enough. 
She continued to consume peanuts and have them around the home.  
A few studies have been conducted with the purpose of examining different 
aspects of potential impacts of peanut allergy by the use of surveys. To determine the 
impact of knowledge, Lyons and Forde (2004) interviewed teenagers with and without 
diagnosed food allergies about their knowledge of food allergies. They found that the 
teenagers who had food allergies and who reported feeling competent in managing their 
health also reported higher levels of anxiety. This was in contrast to teenagers who did 
not have a diagnosed food allergy, who tended to report lower levels of anxiety if they 
reported feeling competent about managing their health. This higher level of reported 
anxiety was explained as an artifact of the food-allergic teens need to constantly “scan” 
their environments for potential hazards in order to manage their health effectively. The 
higher anxiety scores found for this sample, while statistically significant, were only 
slightly higher than established norms (45.51 versus 40.17). 
In a different approach, Bollinger et al. (2006) asked the caregivers of 87 children 
with food allergies (85 with peanut allergy) what kind of impact their child’s allergy had 
on their family. Half of the sample reported that their child’s allergy significantly affected 
their family’s social activities including their children playing at friend’s houses, 
attending birthday parties and sleepovers, going out to eat, and parental relationships. A 
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small percentage, 10% of the caregivers, reported home schooling their children due to 
their child’s allergy.  
Also surveying caregivers, Mandell, Curtis, Gold, and Hardie (2005) found that 
parents restricted their child’s independent activities long after other children were 
independent (e.g., accompanying their children to parties, making preparatory phone 
calls). They also reported that their children felt negatively about these restrictions, from 
not being able to eat birthday cakes to not being able to participate in school trips. 
While there have been a few studies linking peanut allergy and higher levels of 
anxiety specifically, there are other studies in the general allergy literature. In the 
literature on allergies generally, evidence has been found for greater levels of anxiety in 
children with allergies. In a study by Kovalenko et al. (2001), two epidemiological 
samples were combined and a relationship between panic disorder and allergies in 
children was found. The authors proposed that, in some cases, food allergy may be 
initially misdiagnosed as panic disorder, and that their similar symptoms may have 
contributed to the relationship found in this study. Slattery et al. (2002) also found a 
relationship between atopic disorders and anxiety. This study looked at the children of 
adults with Panic Disorder, non-panic psychiatric disorders, and non-psychiatric controls. 
The researchers found that the children of parents with Panic Disorder had more atopic 
conditions than children of parents with non-panic disorders. They also found a higher 
rate of atopic conditions among children who had Separation Anxiety Disorder. 
 In addition to the possibility of psychological maladjustment related to peanut 
allergy including anxiety and depressive symptoms, Masia et al. (1998) outlined five 
more areas of functioning which may be important to investigate in the lives of children 
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allergic to peanuts, including: (a) family adjustment, (b) peer relations, (c) school issues, 
(d) adherence to medical regimens, and (e) adequate communication between the child’s 
physician or specialist, the family and the affected child. All five of these areas can add 
stress for the child who has a severe allergy to peanuts and each should be evaluated to 
assess the level of functioning of an affected child.  
Impact on Caregivers 
While the effects of a chronic illness on children can be difficult to cope with for 
a variety of reasons, the impact of the child’s disease on the child’s caretakers must be 
considered as well. While often the adult involved does not suffer from the same illness 
as the child, the adult must become an expert on their child’s illness and its treatment. 
One study that systematically studied the impact of peanut allergy on both children and 
adults (Primeau et al., 2000) compared reports on quality of life by parents of children 
who were allergic to peanuts to those reported by parents of children with a 
rheumatological disease. The parents of children with peanut allergy reported more levels 
of disruption to their children’s daily lives and more specific disruption in family and 
social interactions due to peanut allergy. The researchers used a modified version of the 
European Quality of Life questionnaire, in which respondents were asked to respond to 
questions with regards to the specific illness affecting different areas of their children’s 
lives. To assess the impact of the illness on the family, the respondents were asked to 
complete the Impact on the Family Questionnaire, and again were asked to respond to 
questions in regards to their child’s illness. Although the study did look at quality of life 
in children with peanut allergy, the questions were very specifically worded to elicit 
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responses regarding how the parents perceived peanut allergy was related to quality of 
life and not the child’s health related quality of life overall. 
In a survey of 17 parents of children with documented anaphylactic reactions 
(Mandell et al., 2005) parents reported that, when their child was initially diagnosed with 
peanut allergy, they felt that they had been given insufficient information regarding 
peanut allergy and they were left feeling anxious, fearful, and unclear about how to safely 
manage their child’s allergy. When asked what information would have been sufficient 
suggestions included; the seriousness of anaphylaxis, a prescription for epinephrine and 
explicit instructions on how to use it, addressing adequate avoidance techniques including 
label reading, cross-contamination avoidance, and trace contamination, and referral to a 
support group or allergy-related organization. The study also found that parents initially 
felt high levels of anxiety over their child’s anxiety which subsided as they felt that they 
had management strategies in place, while a high level of vigilance remained. 
Resurgences of anxiety were reported to occur whenever their child had another allergic 
reaction, when new information regarding mislabeling or new risk factors became 
known, or when their child reached a new developmental level which came with new 
experiences and new levels of independence.  
Although a parent of a child with peanut allergy does not typically have to 
administer daily medications and treatment regimens, she may spend extra time with 
school personnel related to keeping her child safe in school, reading labels to ensure food 
safety and may spend more time at home because outside sources of food may not be safe 
for her child. It will be important to look at parental stressors in the study of peanut 
allergy in children. 
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Psychosocial Treatment 
 Recently, professionals have begun to recognize some of the non-medical impacts 
of peanut allergy and the psychosocial effects on children and families. Coulson and 
Knibb (2007) reported on the use of online support groups for both individuals with food 
allergies and caretakers of children with food allergies. Online support group members 
cited advantages of this format including: easy accessibility of information, social 
support, and learning coping strategies from other members. One disadvantage cited was 
the anonymity of the format which sometimes made it difficult to trust information 
sources. Reactions to how online support groups affected individuals in their 
relationships with healthcare providers was mixed, with some citing that they felt more 
able to participate in treatment and discuss new information, and some reporting 
reluctance on the part of healthcare providers to listen to information retrieved from the 
online format.  
 Monga and Manassis (2006) gave advice to mental health care providers who 
might see children with anaphylactic conditions in their practices. They advised careful 
assessment of anxiety symptoms and to delineate which symptoms were above and 
beyond necessary precautions taken for avoidance of allergens. They also advised using 
cognitive behavioral therapy techniques for treatment of anxiety symptoms and helping 
children to more accurately identify anxiety symptoms as opposed to allergic reactions, 
because symptoms can often overlap. This is clearly a new area of treatment, because 
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children and parents must remain vigilant to allergen threats, but also need to be able to 
function in day to day life.  
Current Study Aims 
 While there have been several studies done with children and parents about their 
children’s peanut allergy or other food allergy, studies have not looked simultaneously at 
both child and parent psychosocial functioning and how it relates to a child’s overall 
quality of life. The current study aimed to gather both child and parent data in the areas of 
child anxiety and parental stress and to compare this to overall functioning of the children 
in terms of health-related quality of life. 
The current study investigated the relationship between HRQOL, parental stress 
and child anxiety in children with peanut allergy. The first set of hypotheses regarded 
individual variables; it was hypothesized that compared to general population norms, 
children with peanut allergy would report higher levels of anxiety on the Revised 
Children’s Manifest Anxiety Scale. It was hypothesized that parent reports of overall 
parenting stress would be higher than published population norms. It was hypothesized 
that children with peanut allergy would report lower Health Related Quality of Life than 
the norms for children without chronic illnesses and that parental report of their 
children’s HRQOL will be similar to their children’s self-report. 
 Second, it was hypothesized that these variables will be interrelated, such that 
child anxiety, parental stress, and the severity of illness reported would contribute to the 
overall reported HRQOL. It was hypothesized that children with more severe peanut 
allergy would experience higher levels of reported anxiety, that their parents would report 
higher levels of parenting stress, and would report feeling less “in control” of their child’s 
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illness, and that these variables will be related to low HRQOL as reported by parents and 
children. 
Method 
Participants 
 Participants were 51 families with at least one school aged (6-12 years) child who 
had been diagnosed with an allergy to peanuts by a licensed physician or allergist. A total 
of 51 primary caretakers (50 mothers and 1 father) completed measures for the study. 
There were 48 children with peanut allergy who completed their own measures. Three 
children did not complete measures because their parents deemed the measures to be too 
stressful for their children before they attempted to complete them (2 children) or because 
the child began experiencing anxiety symptoms while completing the measures (1 child). 
Analysis of demographic variables found that the three children who did not participate 
directly did not differ from the children who did participate based on child age, parent 
age, gender, ethnicity, school placement, education level of the parents, length of 
diagnosis, use of epinephrine or hospitalization for allergic reactions, or reported levels of 
parenting stress, control or fear. They did differ from the other child participants on one 
variable, social functioning on the PedsQL™, with their parents rating their social 
functioning as lower than other children who participated (F (1, 49) = 6.41, p = .015). 
The decision was made to keep the parent data of these three children in the analysis in 
order to preserve the variability in the sample. Although these subjects were kept in the 
sample, their data did not figure into the regression analyses, because the child anxiety 
variable was used in both models. Primary caretakers of children with peanut allergy 
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were recruited from peanut allergy support websites and allergy clinics across the United 
States.  
Procedure 
 A general message asking for interested volunteers was posted on a peanut allergy 
support website (www.peanutallergy.com) instructing the volunteers to contact the 
researcher by e-mail if they were interested in participating. The announcement was 
updated every two months and questions on the discussion board or received by e-mail 
about the study were answered within 48 hours of posting.  For recruitment from allergy 
clinics, a search on the American Academy of Allergy and Immunology website was 
completed for allergists with specialties in children and food allergy. Two allergists were 
chosen for each state. Allergists’ names were chosen from different practices and 
different cities if possible. When a search yielded no pediatric allergists with a 
specialization in food allergy, an allergist serving children was chosen. For states with 
major metropolitan areas (New York City, Los Angeles, etc) three allergists were chosen, 
with one outside the major metropolitan area. Information regarding the study with a 
flyer was included in a mailing to each allergist. Allergists were asked to explain the 
study to their patients with peanut allergy and/or post the flyer in their waiting room.  
After an initial explanation of the study via e-mail or by their physician, a packet of 
consent forms and questionnaires was mailed to the participant’s homes by the principal 
investigator. Included in the packet of measures were a written consent form for the 
child’s primary caretaker and a written assent form for the child, a reimbursement form, 
and self-addressed stamped envelope for sending the packet back to the investigator. Out 
of the 90 packets that were mailed, 51 were returned, yielding a response rate of 56.67%. 
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 The primary caretakers were asked to fill out several questionnaires about their 
child and family including; a demographic information page, the Pediatric Quality of Life 
Inventory™ Version 4.0 (PedsQL), the Parenting Stress Index (PSI), and a list of quality 
of life questions geared specifically towards peanut allergy (Appendix A). These 
questionnaires took approximately one hour to complete. The child participants were 
asked to fill out the PedsQL, the RCMAS, and the peanut allergy specific questions. The 
child questionnaires took approximately 30 minutes to complete. 
Measures 
The Pediatric Quality of Life Inventory™ Version 4.0 
 The 23-item Pediatric Quality of Life Inventory™ Version 4.0 Generic Core 
Scales (PedsQL 4.0) encompass four domains: physical, emotional, social and school 
functioning. Child self-report includes versions for 5-7, 8-12, and 13-18 years of age. 
Parent report includes versions for children 2-4, 5-7, 8-12, and 13-18 years of age (Varni, 
Seid, Knight, Uzark, & Szer, 2002). A five point Likert scale is used for most self and 
proxy reports, except for the 5-7 year old self report version which was simplified to a 3 
point scale. All items are reverse-scored and transformed to a 0-100 point scale so that 
higher scores indicate better HRQOL. 
 Validation studies done on the PedsQL™ have shown that the scale is able to 
differentiate between healthy children and those with acute or chronic health conditions 
(Varni, Seid, & Kurtin, 2001). Healthy children have shown higher scores than acute and 
chronically ill children by self-report. By proxy report, acutely ill children have also 
consistently shown higher scores than chronically ill children. Across all age groups, 
internal consistency and reliability were found to be α = 0.88 for self report and 0.90 for 
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proxy report. School functioning exhibited the lowest reliability coefficients at 0.68 for 
self report and .76 for proxy report, but was increasingly consistent with increased age of 
the child across both types of report. The current study found overall reliability estimates 
(α) of 0.89 for the self report and 0.87 for the proxy report.  
Parenting Stress Index 
 The Parenting Stress Index (PSI) is a 120 item questionnaire for parents of 
children aged one to 12 years old (Abidin, 1995). Most items require a response on a 5 
point scale ranging from strongly agree, agree, and not sure, to disagree and strongly 
disagree. Items that require different answers are preceded by a cue. Items 102-120 
require yes/no responses to a list of life events that may have occurred in the past 12 
month period. The items assess a variety of areas, including child characteristics that may 
increase parental stress and parent characteristics that may increase stress. Reliability 
coefficients for internal consistency for the Parent and Child domains and the Total Stress 
score are reported at .90 or greater (Abidin, 1995). Test-Retest reliability obtained for an 
interval of 1 to 3 months was .63 for the Child Domain, .91 for the Parent Domain, and 
.96 for the Total Stress score (Abidin, 1995).  For the current study a reliability 
coefficient of α = .78 was found for the entire scale. 
Revised Children’s Manifest Anxiety Scale 
 The Revised Children’s Manifest Anxiety Scale (RCMAS) is a 37 item scale for 
children age 6 to 19 years old (Reynolds & Richmond, 1985). The scale is a dichotomous 
yes/no scale that assesses three factors of anxiety; physiological, oversensitivity, and 
fear/concentration aspects. It also contains a lie scale to assess whether the child is 
answering in a manner that suggests a need to portray their behavior as ideal. For Total 
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Anxiety scores, reliability estimates were .82 across all age groups, ranging from .79 to 
.85. The anxiety subscales by themselves are less consistent, with reliability estimates 
across all age groups, male and female, black and white subjects ranging from .64 for the 
Social Concerns/Concentration subscale, .67 for the Physiological subscale, to .76 for the 
Worry/Oversensitivity subscale. For the current study, the reliability coefficient for the 
whole measure was found to be α = .71. 
Peanut Allergy Experiences Questions 
 A series of specific peanut allergy questions were asked of both parents and child 
participants (see Appendix A). These questions, generated by the principal investigator, 
included issues pertaining to illness severity (number of allergic reactions, number of 
emergency room visits, etc.), illness length (age of diagnosis/first reaction), illness 
experience (allergy symptoms, epinephrine training, etc.), and parental feelings of control 
over their child’s illness. For parent’s feeling of control and fear, the three items yielded a 
Cronbach’s alpha of .76. During the course of the study, two additional questions were 
added, including; “Does you child also have a diagnosis of asthma?” and “Please list any 
additional food allergies that your child has.”  
Results 
Sample Characteristics 
 Fifty one families were recruited through online discussion groups and solicitation 
of allergy clinics throughout the United States. Fifty mothers and 1 father acted as 
respondents for their children (26 female and 25 male). The sample was 94.1% 
Caucasian, with the remainder identifying as Asian American (1 child) or Bi-racial (2 
children). Many of the families reported higher than average incomes (37.3% = 
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$100,000/year or more, 21.6% = $80-100,000/year, 15.7% = $60-80,000/year, 17.6% = 
$40-60,000/year, 2% = 20-40,000/year, and 2% = 0-20,000/year). Parental education was 
also higher than the general population (35.3% = Graduate degree, 43.1% = Bachelor’s 
degree, 9.8% = Associate’s degree, 7.8% = some college, 3.9% = High school). Of the 
parent respondents, 94.1% were married. The responding parents’ ages averaged 39.5 
years (SD = 4.3), with their partners averaging 41.5 years of age (SD = 4.2). 
 The children in the study ranged from 6 to 12 years old (M = 8.1, SD = 1.8). The average 
age at which they were diagnosed with peanut allergy was 1.8 years (range = 1 to 5 years, 
SD = 1.1). The average length of diagnosis was 6.4 years (range = 2-11 years, SD = 2.3). 
The children in the sample had experienced an average of 2.3 reactions to peanuts (range 
= 0-5, SD 1.5). Regarding initial reactions, 62.7% occurred with peanut butter and 19.6% 
with peanuts. Three of the children in the study had been diagnosed with a peanut allergy 
by a blood test or skin prick test and therefore had never had a reaction outside the 
doctor’s office. Of the 39 parents who provided an answer to the question of whether or 
not their child had a diagnosis of asthma, 25 reported that their child did indeed also have 
asthma. Of the 42 parents who answered the question of whether or not their child had 
any additional food allergies, 29 responded that their child was allergic to one or more 
additional foods.   
During their first reaction, 49% of children received only Benedryl®, 3.9% 
received a shot of epinephrine but were not hospitalized, and 15.7% went to the hospital 
after treatment with Benedryl® or epinephrine. An alarming 27.5% received no treatment 
for their first reaction. For subsequent reactions, 21.6% of children went to the hospital. 
Thirty five percent of the children had had an allergic reaction requiring treatment with a 
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shot of epinephrine, and the average number of lifetime epinephrine shots was less than 
1, between 0 and 3 (SD = .90). Nearly seventy five percent of the children reported that 
they had been shown how to use an Epipen®. The average age of training was reported as 
5.68 years (SD = 1.8 years). The majority of the children attended public schools 
(72.5%), with some children attending private schools (17.6%) and some being home 
schooled (9.8%). 
A series of ANOVAs were completed to ascertain whether or not the main 
variables differed based on recruitment method, asthma status, or multiple allergy status. 
Of the 51 participants, 35 were recruited through the internet discussion group, 12 from 
allergists, and 4 from informal referrals. The different referral groups did not differ 
significantly on any of the major study variables or demographic variables. 
Thirty-nine parents reported on whether or not their child also had a diagnosis of 
asthma, with 25 reporting that their child also carried a diagnosis of asthma. For asthma 
status, the asthma group and non-asthma group significantly differed on the following 
measures; self-report total score on the PedsQL, proxy-report total score on the PedsQL, 
and PSI parenting stress score. The asthma group had lower scores on the PedsQL 
measures, indicating lower health-related quality of life, and lower scores on the PSI, 
indicating lower parental stress levels for children diagnosed with asthma. 
For multiple allergy status, 42 parents reported on this variable, with 29 parents 
reporting that their child suffered from multiple food allergies, most often tree nut 
allergy. The multiple allergy group differed significantly from the peanut allergy only 
group on two variables, self-report of social functioning on the PedsQL and parenting 
stress on the PSI. The parents of children with multiple food allergies reported higher 
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levels of parenting stress and their children reported lower levels of social functioning 
ability on the PedsQL. 
T-tests 
T-tests were conducted to ascertain whether the sample of children with peanut 
allergy and their parents as a whole had reported more anxiety symptoms, more parental 
stress, or lower health related quality of life than normal controls according to population 
estimates.  
 The RCMAS was used to assess child anxiety. Based on 48 child responses, the 
overall sample had a mean T-score of 41.15 (range = 24-63, SD = 9.2). This score was 
significantly less than the average T-score of 50 (t (47) = -6.67, p < .001). The same was 
true for the majority of the subscales on the RCMAS which have an average scaled score 
of 10 with a standard deviation of 3. Physical symptoms averaged a scaled score of 7.4 
(range = 2-14, SD = 2.8) and was significantly lower than average (t (47) = -6.46, 
p<.001). Worry symptoms averaged a scaled score of 7.6 (range = 3-15, SD = 2.8), again 
significantly lower than the average (t (47) = -5.89, p < .001). Social Anxiety symptoms 
averaged a scaled score of 7.1 (range = 4-11, SD = 2.2), significantly lower than the 
average scaled score of 10 (t (47) = -9.06, p < .001). The exception was for the Lie scale, 
which yielded a mean scaled score of 10 for the sample (range = 5-17, SD = 3.2) which 
was not significantly different than the average scaled score of 10 (t (47) = 000,  
p = 1.0). 
 For the Parenting Stress Index (PSI) the percentile for Total parental stress 
averaged 45.8% (range = 1-99, SD = 29.2), the average for Child related stress was 
46.7% (range = 3-99, SD = 33.4), the average for Parent related stress was 45.7% (range 
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= 1-97, SD = 27), and the average for Life event stress was 31.9% (range = 0-98, SD = 
31.4). Compared to an average at the 50th percentile, Total stress (t (50) = -1.0, p = .31), 
Parent related stress (t (50) = -1.1, p = .26), and Child Stress (t (50) = -.71, p = .48) were 
not significantly different from average stress levels. Average life stress percentiles were 
significantly lower than average (t (50) = -4.11, p < .001). 
 For the PedsQL 4.0™, the average scores of healthy controls reported by Varni, 
Burwinkle, Seid, and Skarr (2003) were used to compare to the current sample (see Table 
1). For the child report of health-related quality of life, the only comparison that showed 
a statistically significant difference was obtained for the comparison between the current 
sample and healthy controls on the emotional functioning scale. The current sample of 
children with peanut allergy had lower mean scores on emotional functioning when 
compared to the healthy control norms. 
Table 1 
Child Report on the Peds-QL versus Healthy Control Norms 
 Current Peanut 
Allergy 
Sample 
M (SD) 
Healthy Controls 
(Varni et al., 2003) 
 
M (SD) 
Comparison result 
PedsQL Total 82.38 (11.64) 83.91 (12.47) t (47) =  -0.92,  p < .36 
Peds QL: Physical 88.06 (11.67) 87.77 (13.12) t (47) =   0.18,  p < .29 
PedsQL: Psychosocial 79.08 (13.03) 81.83 (13.97) t (47) =  -1.48, p <  .15 
PedsQL: Emotional 73.89 (16.04) 79.21 (18.02) t (47) =  -2.33, p <  .02 
PedsQL: Social 82.29 (15.60) 84.97 (16.71) t (47) =  -1.19, p <  .24 
PedsQL: School 81.33 (14.90) 81.31 (81.31) t (47) =   0.01, p <  .99 
 
 
PedsQL: Pediatric Quality of Life Inventory 
M: Mean score 
SD: Standard Deviation 
 
For the proxy-reports of child health related quality of life, there were more 
comparisons that were statistically significantly different (see Table 2). The current 
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sample of parents of children with peanut allergy reported higher scores for their children 
for physical functioning and school functioning and lower scores for emotional 
functioning compared to published norms for healthy controls (Varni et al., 2003).  
 
Table 2 
Parent Proxy Report on the Peds-QL versus Healthy Control Norms 
 Current Peanut 
Allergy 
Sample 
M (SD) 
Healthy Controls 
(Varni et al., 2003) 
 
M (SD) 
Comparison result 
PedsQL Total 83.12 (10.47) 82.91 (15.55) t (50) =    0.57,  p < .57 
Peds QL: Physical 89.95 (11.63) 84.08 (19.70) t (50) =    3.6,    p < .001 
PedsQL: Psychosocial 79.48 (12.04) 81.24 (15.34) t (50) =   -1.05,  p < .30 
PedsQL: Emotional 70.49 (15.66) 81.20 (16.40) t (50) =   -4.88,  p < .001 
PedsQL: Social 84.41 (14.41) 83.05 (19.66) t (50) =     0.68,  p < .50 
PedsQL: School 83.53 (14.05) 78.27 (19.64) t (50) =     2.67,  p < .01 
 
 
PedsQL: Pediatric Quality of Life Inventory 
M: Mean score 
SD: Standard Deviation 
 
  Because of this variability, a further investigation of the most highly 
distressed third of the sample (N = 17) versus the other two thirds was conducted. The 
most highly distressed members of the sample were identified by the 17 highest scores on 
the Parenting Stress Index. The average PSI total score for the highest distress group was 
81.65 (range = 63-99, SD = 10.9). The average child anxiety score for this group was 
46.2 (range = 31-63, SD = 9.5). The number of children in this group with multiple food 
allergies was 12 (70.6%), and 10 of these children had a diagnosis of asthma. This is in 
comparison to the least distressed group, the participants with the 17 lowest scores on the 
PSI, who had an average PSI score of 15.5 (range = 1-29, SD = 9.3). The least distressed 
group had an average child anxiety score of 38.47 (range = 25-53, SD = 8.2). The number 
 28 
of children with multiple food allergies in the least distressed group was 9 (52.9%) and 
eight of the children had asthma. 
Correlations 
 An intercorrelational matrix was constructed to ascertain relationships between 
demographic variables and study variables. Child age, child gender, and child ethnicity 
were not significantly correlated with any other study variables. Due to the size of the 
intercorrelational matrix, only significant results are discussed here. Family income was 
significantly correlated with marital status (r = -.29, p = .04), with higher income related 
to having married parents. Family income was also positively correlated with parents 
feeling in control of their child’s allergy (r = .34, p = .02) and parents less often feeling 
afraid that their child would have an allergic reaction (r = .30, p = .04). The type of 
school a child attended (public, private, home school) was correlated with a child’s self-
report of their physical functioning (r = -.32, p < .03) and parent report of their child’s 
overall quality of life (r = -.279, p < .05). For both variables, the children who were 
home-schooled had lower average quality of life scores (see Figures 1 and 2).  The 
direction of this relationship is unclear, whether children who report more physical 
symptoms are more likely to be home-schooled or whether home-schooled children 
report more physical symptoms. Mean scores on physical symptom questions by school 
type are presented in Table 3. Children who were home-schooled reported lower scores 
on several questions such as hurting or aching, having difficulty lifting heavy items, and 
having trouble walking more than one block. It is unknown whether these children were 
home-schooled because of their peanut allergy, because of other ailments, or because of 
some other reason unknown to the researcher. 
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Figure 1 
PedsQL 4.0 Self-Report of Physical Functioning by Type of School Placement 
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Figure 2 
PedsQL 4.0 Total Score Parent Proxy Report by School Placement 
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Table 3 
Self-report of Physical Symptoms on the PedsQL™ 4.0 by School Placement 
Physical 
Symptoms 
on the 
PedsQL™ 
4.0 
Public School 
N = 37 children 
M (SD) 
Private School 
N = 9 children 
M (SD) 
Home Schooled 
N = 5 children 
M (SD) 
Hard to 
walk more 
than one 
block  
95.14 (11.67) 100 (0) 80 (27.39) 
Hard to run 93.06 (15.37) 83.33 (25.00) 90 (22.36) 
Hard to do 
sports or 
exercises 
93.75 (13.86) 88.89 (22.05) 
 
 
80 (27.37) 
Hard to lift 
something 
heavy 
86.81 (20.25) 88.89 (18.16) 65 (22.36) 
Hard to take 
a bath or 
shower 
95.83 (12.68) 100 (0) 90 (22.36) 
Hard to do 
chores 
around the 
house 
90.97 (19.04) 80.56 (30.05) 75 (25) 
Hurting or 79.51 (20.74) 77.78 (26.35) 60 (22.36) 
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aching 
Low Energy 85.07 (21.30) 66.67 (21.65) 85 (33.54) 
        M: Mean total 
        SD: Standard Deviation 
 
The number of allergic reactions as reported by parents was positively correlated 
with the number of epinephrine shots a child had over their lifetime (r = .39, p = .005), 
with how often their parent was afraid of their child having a reaction (r = -.35, p = .01) 
(reverse scored 1= always afraid), and how afraid their parents were that they would have 
a reaction (r = -.38, p = .007) (1 = very afraid). There were also significant correlations 
between child anxiety, parenting stress, and health related quality of life variables (see 
Tables 4 and 5). Both child report and parent report of child health related quality of life 
were correlated to measures of parenting stress and child anxiety. 
 
Table 4 
Parent Report on the Peds-QL correlations with PSI and RCMAS 
 PedsQL 
Total 
PedsQL-
Physical 
PedsQL- 
Social 
PedsQL-
Emotional 
PedsQL-
School 
PSI Total -.43** -.33* -.39** -.31* -.30* 
PSI Child -.40** -.23 -.41** -.32* -.32* 
PSI Parent -.32* -.32* -.24  .29 -.18 
RCMAS Total -.59** -.50** -.46** -.52** -.32* 
RCMAS Physical -.48** -.52** -.35* -.29* -.29* 
RCMAS Worry -.45** -.38** -.31* -.47** -.21 
RCMAS Social -.50** -.36* -.45** -.36* -.39** 
 
 
*p < .05, **p < .01 
PedsQL: Pediatric Quality of Life Inventory 
PSI: Parenting Stress Index 
RCMAS: Revised Children’s Manifest Anxiety Scale 
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Table 5 
Child Report on the Peds-QL correlations with PSI and RCMAS 
 PedsQL 
Total 
PedsQL-
Physical 
PedsQL- 
Social 
PedsQL-
Emotional 
PedsQL-
School 
PSI Total -.48** -.38** -.37* -.34* -.37** 
PSI Child -.44** -.37* -.38** -.32*  .33* 
PSI Parent -.37** -.45** -.20 -.29* -.29* 
RCMAS Total -.67** -.63** -.53** -.55** -.52** 
RCMAS Physical -.51** -.58** -.41** -.33* .-37** 
RCMAS Worry -.55** -.49** -.36* -.55** -.42** 
RCMAS Social -.57** -.44** -.56** -.39** -.52** 
 
 
*p < .05, **p < .01 
PedsQL: Pediatric Quality of Life Inventory 
PSI: Parenting Stress Index 
RCMAS: Revised Children’s Manifest Anxiety Scale 
 
Regression Analyses 
Regressions were conducted using both Parental Proxy-report of child health 
related quality of life and Child Self-report of health related quality of life. It was 
hypothesized that child anxiety, parenting stress, and severity of illness would all 
contribute to health-related quality of life in children with peanut allergy.  
The first set of regression analyses was conducted with Parental proxy-report of 
child health-related quality of life as the outcome variable. Variables were entered step-
wise to assess their individual contributions to the regression model. Variables were 
entered in the following order: (1) length of diagnosis; (2) number of allergic reactions to 
peanuts; (3) whether or not the child had ever had a shot of epinephrine; (4) the three 
variables of how in control the parent felt about their child’s allergy, how often and how 
afraid they were that their child would have a reaction; (5) parenting stress total score; 
and (6) child anxiety total score. Variables were entered in six blocks, with severity 
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variables entered first and psychosocial variables entered next in order to ascertain more 
accurately levels of variance accounted for. With the stepwise entry method, the model 
explained the most variance in health-related quality of life scores, explaining 53.7% of 
the variance. The regression model was significant, R2 = .54, adjusted R2 = .44, F (8, 38) 
= 5.49, p < .001. This model has a large effect size and a power estimate of 0.95 using 
GPower to calculate results. The significant predictors in the model included parenting 
stress and child anxiety, with very little contribution by the other predictors (see Table 6). 
A second analysis using only child anxiety and parenting stress as predictors found that 
these two variables counted for 39.9% of the variance in child health-related quality of 
life (B = (parenting stress = -.290), (child anxiety = -.518) . Severity of illness and 
feelings of control or fear by the parents were not significantly predictive. 
Table 6 
Summary of Regression Analysis Testing Parent report of Health-related quality of life 
Variable B P F R2 ∆R2 
Step 1   .007 .000  
    Length of diagnosis  .040 .94    
Step 2   .968 .042 .042 
    Number of allergic    
    Reactions 
-.435 .63    
Step 3   1.626 .102 .060 
     Epinephrine shot 
     Ever 
 2.246 .06    
Step 4   .914 .121 .019 
     Control over allergy 1.303 .07    
     How often afraid -.536 .49    
     How afraid -.099 .89    
Step 5   3.071 .355 .234 
     Parenting Stress     
     Total* 
-.105 .03    
Step 6   5.499 .537 .182 
     Child Anxiety  
     Total** 
-.582 .001    
 
* p < .05. ** p < .01. 
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The second set of regression analyses used self-reported health-related quality of 
life as the outcome measure. Variables were again entered step-wise in the following 
order: (1) length of diagnosis, (2) whether or not the child had an allergic reaction 
requiring a shot of epinephrine (1= yes, 2 = no), (3) parenting stress, and (4) child 
anxiety. Again variables were entered in the above four blocks with severity variables 
entered first and psychosocial variables entered after to ascertain individual variance 
contributions. The regression model was significant, R2 = .59, adjusted R2 = .56, F (4, 43) 
= 16.03, p < .001. This model also yields a large effect size and has a power estimate of 
0.98, using GPower. In the model, all of the variables contributed significantly (B (length 
of diagnosis = .225), (epinephrine required = .214), (parenting stress = -.233), (child 
anxiety = -.569), (see Table 7). Children’s health related quality of life was negatively 
affected by their own anxiety and their parent’s stress and positively affected by how 
long they had been living with their diagnosis and if they had not had a reaction requiring 
a shot of epinephrine.     
Table 7 
Summary of Regression Analysis Testing Child reported Health-related quality of life 
Variable B P F R2 ∆R2 
Step 1   2.104 .044  
    Length of diagnosis* 1.172 .03    
Step 2   2.837 .112 .068 
     Epinephrine shot 
     Ever* 
 2.407 .04    
Step 3   7.555 .340 .228 
     Parenting Stress     
     Total* 
-.095 .04    
Step 4   16.032 .599 .259 
     Child Anxiety  
     Total** 
-.722 .001    
* p < .05. ** p < .01. 
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MANOVA 
 Further analyses were conducted comparing the least distressed and most 
distressed portions of the sample to see how they may have differed in overall 
functioning. A MANOVA was conducted to compare the highest, lowest, and middle 
third of the sample as delineated by their PSI scores. The overall MANOVA was 
significant for the three groups based on their Self-reported and Parent-reported PedsQL 
4.0 scores, Wilk’s Λ = .74, (F (2, 45) = 3.7, p < .008). The multivariate η2 = .87 indicates 
that 87% of the variance of the PedsQL 4.0 score was accounted for by level of distress 
on the PSI. Post-hoc analysis using the LSD method and comparing the groups at the 
.008 level of significance revealed significant differences between the highest and lowest 
groups (p < .001) for child report of health-related quality of life, with the more highly 
distressed group having significantly lower health-related quality of life scores. There 
was also a statistically significant difference between the highest and lowest distress 
groups based on parent report of health-related quality of life ( p < .001), with parents 
who were highly distressed reporting lower health-related quality of life in their children.   
Discussion 
This study sought to look at the possible psychosocial effects of peanut allergy on 
children. Although peanut allergy has become an increasingly reported on topic in the 
media with countless news reports on increased prevalence and effects on school policies 
and procedures, to date most research on peanut allergy has focused on the medical 
impact of the illness. Peanut allergy is a chronic illness that affects all aspects of a child’s 
life, restricting their activities and their family’s activities and requiring a high level of 
vigilance to avoid contamination or accidental ingestion. Peanut allergy is most likely not 
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different than many other chronic illnesses found in children in its effects on families 
lives. 
Overall, the sample was highly variable in their reported experiences, with some 
families reporting multiple reactions to peanuts and multiple reactions requiring shots of 
epinephrine and subsequent hospitalizations and some families having only experienced a 
diagnosis of peanut allergy by blood or skin test and no reactions. As a result, parental 
stress levels and child anxiety levels also varied. Although many of the t-tests did not 
show significant differences for the peanut allergy group compared to population norms, 
this is most likely due to the high variability of scores on each measure. For each 
subscale, scores ranged from very low to very high, which when averaged together 
yielded means that were consistent with average population means. 
Although most measures did not show the sample as a whole to differ from a 
healthy population, this is most likely due to the variability in severity and experience of 
peanut allergy. Asthma and multiple allergy status as reported by part of the sample also 
indicated differences in functioning dependent on multiple determinants. While the 
parents who reported that their children also had asthma reported lower levels of 
parenting stress, parents of children with multiple food allergies reported greater levels of 
parenting stress. Both groups indicated that they had lower health-related quality of life 
across several different domains. It will be important in the future to compare asthma and 
multiple allergy status when discussing the impact of peanut allergy. Subsequent analyses 
of those in the sample who were more highly distressed versus those who were less 
distressed reinforced the findings that the more highly distressed members of the group 
had lower health-related quality of life. 
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As reported in other studies, some parents of children with peanut allergy are 
choosing to home school their children in order to reduce potential reactions in the school 
environment (Bollinger et al., 2006). The current study found approximately the same 
percentage of home-schooled children in this population at a rate of 10%. Interestingly, 
the children in this study who were home schooled reported lower levels of adequate 
physical functioning and their parents reported less overall health related quality of life. 
The direction of this relationship is unknown, it is possible that children with lower 
health-related quality of life are more likely to be home schooled, or that parents who 
home school their children see them as more disabled because of their allergy. It is also 
possible that the children who were home-schooled in this sample may have been 
suffering from another ailment besides peanut allergy. It will be important in future 
studies to delve deeper into the why of home-schooling for these particular children. If 
the reason for home-schooling is because their children have peanut allergy and they fear 
reactions at school, professionals need to help both parents and school districts learn to 
manage this chronic illness more effectively. Although many schools have medical action 
plans for their students as suggested by the American Academy of Pediatrics (2001), 
many parents have anecdotally reported difficulty in receiving appropriate precautions 
and care for their children who are allergic to peanuts. Some parents may believe that 
having a peanut-free lunch table or one peanut free classroom may not be enough to 
protect their child, while parents of children without peanut allergy may feel that banning 
all peanut products from a school is overzealous.   
Parental feelings of control and feelings of fear of allergic reactions in their 
children were related to SES. Parents with higher levels of income and higher levels of 
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education felt more in control and reported being less afraid. Although this relationship is 
unclear, it could be that, as income increases, access to treatment resources increases and 
this increases feelings of control and decreases fear. Higher income often translates into 
higher quality of medical care in the United States and this may influence parents’ 
perceptions of their children’s medical care. It has been found that people with lower 
income levels and less education are often more skeptical of medical care and physicians’ 
ability to treat their medical symptoms (Fiscella, Franks, & Clancy, 1998). If parents of 
children with peanut allergy feel frustrated because their physicians do not have answers 
for them and they do not feel as if their child is receiving quality medical care, they may 
feel more anxious and less in control of their child’s allergy. 
The results of this study strongly suggest that for children with peanut allergy, 
parental perceptions of their health-related quality of life are related to how much anxiety 
the child reports and how stressful parents perceive their lives to be. This study also 
found that children’s perceptions of their own health-related quality of life are also 
related to how much anxiety they feel and how stressful their parents perceive their lives 
to be. It is quite easy to imagine why these parents feel more stress in their parenting role, 
because of the level of vigilance required to keep their children safe. They must read all 
food labels, ensure that their child always has an epinephrine shot available, and arrange 
for an adult to be with the child who knows how to use the shot at all times. This 
vigilance is a struggle every day, with decisions on where their child is allowed to go and 
whether or not their child can participate in normal school and extracurricular activities 
and still be safe. The parent may feel as if they need to supervise the child at all times and 
may not want to relinquish controls to other adults. Also, more concretely, children’s 
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quality of life is also affected by how long they have had their diagnosis (and presumably 
how old they are) and if they have had to have an epinephrine shot to treat their allergic 
reactions. Self-injecting or having someone else inject epinephrine into one’s body after 
accidentally ingesting something that is causing physical symptoms such as difficulty 
breathing could be considered a traumatic event, especially if the adults around the child 
are also experiencing high levels of stress and worry around the event. One thing to 
investigate in the future is whether or not these children are experiencing symptoms of 
post traumatic stress related to their experiences of emergency medical care for their 
allergy. 
The effects of peanut allergy are not only medical and physiological they also 
affect children’s health related quality of life. How much their quality of life is affected 
appears to be related to how children and their parents cope with their allergy and other 
parts of their lives. This is clearly a complex issue that merits not only continued 
investigation by researchers, but requires information dissemination to practitioners who 
will likely begin to encounter more of these children and their families in their practices. 
As children with peanut allergy feel heightened anxiety about having allergic reactions 
and their parents feel increased amounts of parenting stress related to their child’s allergy, 
many mental health practitioners will find these cases being referred for treatment. As 
this occurs, mental health practitioners will need to understand the issues involved 
including the need for vigilance in avoiding peanuts while not becoming hypervigilant to 
the point of disruption of family life. Disease-specific interventions, focused on how to 
avoid peanut products while still living a relatively normal life may be needed. Specific 
interventions may need to be newly created, because typical cognitive behavioral therapy 
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protocols for the treatment of anxiety usually involve exposing the patient to the feared 
stimuli, which in this case would be life-threatening. Targeted group support and family 
treatments may be needed in order to foster a sense of community among parents and 
families and a sense of control for everyone involved. 
It may also be useful to create a disease specific health-related quality of life scale 
for peanut allergies, as has been done for other illnesses (e.g., asthma, cancer; Varni, 
Burwinkle, Katz, Meeske, & Dickinson, 2002). Some of the effects of peanut allergy 
such as decreased opportunities for dining out and participation in birthday parties and 
sleepovers appear to be unique to the experience of children with peanut allergy. As a 
result, a health-related quality of life scale specifically geared towards peanut allergy 
would help practitioners and researchers to detect severity of the impact of the illness in 
particular children.   
 Over the past few years there has also been speculation in the medical community 
about the potential of creating a vaccine against peanut protein to help protect children 
allergic to peanuts against accidental exposure. In fact, a vaccine was in development, 
TNX-901, an anti-IgE therapy drug that reportedly allowed test subjects to ingest up to 
the equivalent of 6 to 8 peanuts without a reaction (Leung et al., 2003). The project was 
ended when two drug companies began trying to block a smaller company, the 
manufacturer of TNX-901, from continuing to make the drug in favor of an unproven 
drug, Xolair® (Hamilton, 2005). The decision to stop manufacture of the drug terminated 
the clinical trials and crushed the hopes of many parents. If and when the drug companies 
are able to overcome their arguments and begin the trials again, there may be an effective 
treatment for children of peanut allergy. This would relieve much of the fear, anxiety, and 
 42 
stress that children with peanut allergies and their parents feel. If the vaccine does come 
into existence and use, the results of a follow-up to this study could be very different. If 
there were a viable treatment options to alter the effects of accidental ingestion, it is 
possible that many of the psychosocial impacts of this allergy could also be altered and 
even erased for most if not all children with peanut allergy. If a complete vaccine became 
available, one that erased all the effects of peanut allergy, these peanut allergic 
individuals might even be able to eat peanuts outright without the fear of an allergic 
reaction. In that case, a follow-up study of these and other peanut allergic children after 
the introduction of the vaccine would be needed to investigate the possibility of long-
lasting psychological effects. 
 There would also need to be research done on the acceptability of these vaccines 
to children and their parents. Questions of whether childhood vaccines increase the rates 
of autism and whether vaccinating teenagers against sexually transmitted diseases 
increases promiscuity continue to be proposed in nightly news stories. Although a 
vaccine for peanut allergy is not likely to be as controversial as a vaccine against a 
sexually transmitted disease for teenagers, parents may be reluctant to have their children 
vaccinated for a variety of personal reasons (Dempsey, Zimet, Davis, & Koutsky, 2006). 
The vaccine may also have side-effects that are not known at this time and this may cause 
reluctance on the part of parents to have their children vaccinated. Risks and rewards of 
the potential vaccine will have to be evaluated as the vaccine becomes available and 
parents and their children will have to negotiate this decision together (Rupp, Rosenthal, 
& Middleman, 2006). 
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Limitations 
 The sample in this study was primarily Caucasian, highly educated, and had 
substantial incomes. These sample characteristics may be due in part to recruitment 
techniques which used internet-based support groups and recruitment through specialty 
clinics. A more ethnically, educationally, and income diverse sample of participants may 
be found in hospital emergency rooms and general pediatric clinics. Due to the relatively 
low prevalence of peanut allergy overall, multi-site specific recruitment with a large 
number of hospitals and clinics will be required in the future. As the field moves forward 
and more mental health practitioners become aware of psychosocial problems in children 
with peanut allergy, this type of study may become more necessary and accordingly, 
more feasible.  
Conclusion 
 The results of this study have shown that peanut allergy is not only a topic for 
news outlets in the United States; peanut allergy is a real health problem that affects an 
increasing number of children and families in this country. Similar to many medical 
disorders that affect children (asthma, juvenile rheumatoid arthritis, cystic fibrosis, etc.) 
peanut allergy can affect a child not only medically, but psychosocially. This disorder has 
the potential to disrupt psychological functioning, increase parenting stress, and affect a 
child’s entire family. As such, the impact of this ailment should not be underestimated by 
physicians or mental health professionals. As the incidence rate of this allergy continues 
to climb, pediatric psychologists need to be at the forefront of the research into the 
possible effects of this allergy on children’s development and the treatments to help 
children and families cope with this life-altering diagnosis.   
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Appendix A 
Peanut Allergy Experiences Questions 
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Peanut Allergy Impact: Parent version 
What is your child’s age? ____ What is your child’s gender?_____ 
1.) At what age was your child first diagnosed with an allergy to peanuts by a medical 
professional? _____ years old 
2.)  Has your child ever had an allergic reaction to peanuts/peanut products? (Circle one) 
Yes / No 
Regarding your child’s first reaction:  
a) What kind of product was involved? Check all that apply 
 Peanut  Peanut butter  
Peanuts in a prepared dish (Describe_______________________________)  
Peanuts in a packaged food (Describe_______________________________) 
 Unknown 
b) What symptoms were exhibited? Check all that apply    
 Hives/rash   Trouble breathing/wheezing  Stomach ache 
 Anaphylaxis  Swelling of face or other body parts 
  Other, Please Describe __________________________________________ 
c) What treatment was used? Check all that apply  
   Benedryl®/Antihistimine   Epinephrine  No treatment 
   Active Charcoal    Intubation/Ventilation  
   Hospitalization: For how many days?_____ 
4) How many reactions has your child had? Please check one 
   0    2   4-6 
   1     3   6 + (list number ______ 
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If your child has had more than one reaction...... 
What kind of product(s) were involved in other reactions besides the first one? Check all 
that apply 
  Peanuts   Peanut Butter     Peanuts in a prepared dish  
  Peanuts in a packaged food        Unknown 
 What symptoms were exhibited Check all that apply    
 Hives/rash   Trouble breathing/wheezing  Stomach ache 
  Anaphylaxis  Swelling of face or other body parts 
 Other, Please Describe __________________________________________ 
What treatment(s) was/were used? Check all that apply  
  Benedryl®/Antihistimine  Epinephrine   No treatment 
  Active Charcoal   Intubation/Ventilation  
   Hospitalization: For how many days each time? 1x________ 
                 2x________ 
                 3x________ 
 
4) Does your child carry around an emergency kit containing an epinephrine shot? Circle 
one     Yes / No 
a) Has your child been trained to give him/herself a shot of epinephrine?   
Yes / No 
If yes...at what age was she/he trained to do so? ____ years old 
5) Has your child ever had a shot of epinephrine because of an allergic reaction to 
peanuts or peanut products? Circle one Yes / No  
How many?________  
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     In the past year?______ 
a) Has your child ever self-administered a shot of epinephrine for an allergic 
reaction to peanuts? Circle one Yes / No 
How many times? ____ 
In the past year? Yes / No   
How many times?____ 
b) Besides self-administration who has administered epinephrine to your child? 
Check all that apply 
  Doctor   Mother   Father 
 Teacher   School Nurse  Babysitter   
  Child’s peer             Child’s older sibling  
 Child’s younger sibling     Other (Please list________) 
Regarding your child’s illness, how often do you feel “in control” in managing his/her 
peanut allergy? Please circle one number 
1      2  3     4       5        6          7               8             9         10 
never in control   sometimes in control          always in control 
How often are you afraid that your child will have a reaction to peanuts? Please circle 
one number 
1      2  3     4       5        6          7               8             9         10 
always afraid                       sometimes afraid   never afraid 
How afraid are you that your child will have a reaction to peanuts? Please circle one 
1      2  3     4       5        6          7               8             9         10 
very afraid    somewhat afraid      never afraid 
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Peanut Allergy Impact: Child Version 
What is your age?________ What grade are in you in school?________ Are you male or 
female?________ 
Have you ever had a reaction to peanuts?_____ Circle one  Yes / No 
How many times?_____  
  What happened? Did you have... Check all that apply    
 Itchy skin   Couldn’t breathe  Stomach ache 
 Hot feelings  Red skin 
 Other, Please Describe __________________________________________ 
What did people give you for it? Check all that apply  
  Allergy medicine  A shot   Nothing   
  Went to the hospital 
Did you ever have to go to the hospital because of a reaction to peanuts? Circle one 
     Yes / No 
 How many times? ___  
Have you ever had to have a shot because of peanuts? Circle one Yes / No  
How many times?____ 
 Do you carry a shot with you when you go places? Circle one Yes / No  
Do you know how to give yourself a shot? Yes / No  
If yes...How old were you when you were taught how to give yourself a 
shot?_____ years old  
Who taught you? Check all that apply 
 Doctor    Nurse  Mom  Dad   Other __________ 
 
